Cargando…

Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid

BACKGROUND/AIM: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective o...

Descripción completa

Detalles Bibliográficos
Autores principales: DOGAN, İsmail, KALYONCU, Umut, KILIÇ, Levent, AKDOĞAN, Ali, KARADAĞ, Ömer, KİRAZ, Sedat, A. BİLGEN, Şule, ERTENLİ, İhsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080371/
https://www.ncbi.nlm.nih.gov/pubmed/31905492
http://dx.doi.org/10.3906/sag-1908-182
_version_ 1783508008008941568
author DOGAN, İsmail
KALYONCU, Umut
KILIÇ, Levent
AKDOĞAN, Ali
KARADAĞ, Ömer
KİRAZ, Sedat
A. BİLGEN, Şule
ERTENLİ, İhsan
author_facet DOGAN, İsmail
KALYONCU, Umut
KILIÇ, Levent
AKDOĞAN, Ali
KARADAĞ, Ömer
KİRAZ, Sedat
A. BİLGEN, Şule
ERTENLİ, İhsan
author_sort DOGAN, İsmail
collection PubMed
description BACKGROUND/AIM: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. MATERIALS AND METHODS: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. RESULTS: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. CONCLUSION: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients.
format Online
Article
Text
id pubmed-7080371
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-70803712020-03-23 Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid DOGAN, İsmail KALYONCU, Umut KILIÇ, Levent AKDOĞAN, Ali KARADAĞ, Ömer KİRAZ, Sedat A. BİLGEN, Şule ERTENLİ, İhsan Turk J Med Sci Article BACKGROUND/AIM: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. MATERIALS AND METHODS: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. RESULTS: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. CONCLUSION: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients. The Scientific and Technological Research Council of Turkey 2020-02-13 /pmc/articles/PMC7080371/ /pubmed/31905492 http://dx.doi.org/10.3906/sag-1908-182 Text en Copyright © 2019 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
DOGAN, İsmail
KALYONCU, Umut
KILIÇ, Levent
AKDOĞAN, Ali
KARADAĞ, Ömer
KİRAZ, Sedat
A. BİLGEN, Şule
ERTENLİ, İhsan
Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
title Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
title_full Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
title_fullStr Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
title_full_unstemmed Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
title_short Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
title_sort avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080371/
https://www.ncbi.nlm.nih.gov/pubmed/31905492
http://dx.doi.org/10.3906/sag-1908-182
work_keys_str_mv AT doganismail avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT kalyoncuumut avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT kiliclevent avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT akdoganali avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT karadagomer avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT kirazsedat avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT abilgensule avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid
AT ertenliihsan avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid